The conservative view: is it necessary to implant a stent into the dopamine transporter? | Zendy

Schmid D | Zendy; Koenig X | Zendy; Bulusu S | Zendy; Schicker K | Zendy; Freissmuth M | Zendy; Sitte H H | Zendy; Sandtner W | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

The conservative view: is it necessary to implant a stent into the dopamine transporter?

Author(s) -

Schmid D,

Koenig X,

Bulusu S,

Schicker K,

Freissmuth M,

Sitte H H,

Sandtner W

Publication year - 2015

Publication title -

british journal of pharmacology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.432

H-Index - 211

eISSN - 1476-5381

pISSN - 0007-1188

DOI - 10.1111/bph.12766

Subject(s) - dopamine transporter , amphetamine , dopamine , transporter , pharmacology , medicine , chemistry , endocrinology , dopaminergic , biochemistry , gene

Linked Articles This article is a reply to De Felice LJ and Cameron KN (2015). Comments on ‘A quantitative model of amphetamine action on the serotonin transporter’, by Sandtner et al., Br J Pharmacol 171: 1007–1018. Br J Pharmacol 172: this issue, doi: 10.1111/bph.12767 , commenting on Sandtner W, Schmid D, Schicker K, Gerstbrein K, Koenig X, Mayer FP, Boehm S, Freissmuth M and Sitte HH (2014). A quantitative model of amphetamine action on the 5‐HT transporter. Br J Pharmacol 171: 1007–1018. doi: 10.1111/bph.12520

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research